235 related articles for article (PubMed ID: 30256367)
1. Bortezomib-catechol conjugated prodrug micelles: combining bone targeting and aryl boronate-based pH-responsive drug release for cancer bone-metastasis therapy.
Zhu J; Huo Q; Xu M; Yang F; Li Y; Shi H; Niu Y; Liu Y
Nanoscale; 2018 Oct; 10(38):18387-18397. PubMed ID: 30256367
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Evaluation of Reduction-Responsive Alendronate-Hyaluronan-Curcumin Polymer-Drug Conjugates for Targeted Therapy of Bone Metastatic Breast Cancer.
Wang K; Guo C; Dong X; Yu Y; Wang B; Liu W; Chen D
Mol Pharm; 2018 Jul; 15(7):2764-2769. PubMed ID: 29792799
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer.
He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C
J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315
[TBL] [Abstract][Full Text] [Related]
4. A Targeted and pH-Responsive Bortezomib Nanomedicine in the Treatment of Metastatic Bone Tumors.
Wang M; Cai X; Yang J; Wang C; Tong L; Xiao J; Li L
ACS Appl Mater Interfaces; 2018 Dec; 10(48):41003-41011. PubMed ID: 30403331
[TBL] [Abstract][Full Text] [Related]
5. Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases.
Miller K; Clementi C; Polyak D; Eldar-Boock A; Benayoun L; Barshack I; Shaked Y; Pasut G; Satchi-Fainaro R
Biomaterials; 2013 May; 34(15):3795-806. PubMed ID: 23434349
[TBL] [Abstract][Full Text] [Related]
6. Dual ligand-targeted Pluronic P123 polymeric micelles enhance the therapeutic effect of breast cancer with bone metastases.
Gao H; Zhang J; Kleijn TG; Wu Z; Liu B; Ma Y; Ding B; Yin D
Oncol Res; 2024; 32(4):769-784. PubMed ID: 38560569
[TBL] [Abstract][Full Text] [Related]
7. Dual targeting curcumin loaded alendronate-hyaluronan- octadecanoic acid micelles for improving osteosarcoma therapy.
Xi Y; Jiang T; Yu Y; Yu J; Xue M; Xu N; Wen J; Wang W; He H; Shen Y; Chen D; Ye X; Webster TJ
Int J Nanomedicine; 2019; 14():6425-6437. PubMed ID: 31496695
[TBL] [Abstract][Full Text] [Related]
8. Alendronate-Modified Polymeric Micelles for the Treatment of Breast Cancer Bone Metastasis.
Liu T; Romanova S; Wang S; Hyun MA; Zhang C; Cohen SM; Singh RK; Bronich TK
Mol Pharm; 2019 Jul; 16(7):2872-2883. PubMed ID: 31150251
[TBL] [Abstract][Full Text] [Related]
9. Mussel-Derived, Cancer-Targeting Peptide as pH-Sensitive Prodrug Nanocarrier.
Ma Y; He P; Tian X; Liu G; Zeng X; Pan G
ACS Appl Mater Interfaces; 2019 Jul; 11(27):23948-23956. PubMed ID: 31192575
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer.
Ye WL; Zhao YP; Li HQ; Na R; Li F; Mei QB; Zhao MG; Zhou SY
Sci Rep; 2015 Sep; 5():14614. PubMed ID: 26419507
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional redox-responsive and CD44 receptor targeting polymer-drug nanomedicine based curcumin and alendronate: synthesis, characterization and in vitro evaluation.
Dong X; Zou S; Guo C; Wang K; Zhao F; Fan H; Yin J; Chen D
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):168-177. PubMed ID: 29239219
[TBL] [Abstract][Full Text] [Related]
12. Tumor extracellular acidity activated "off-on" release of bortezomib from a biocompatible dendrimer.
Wang M; Wang Y; Hu K; Shao N; Cheng Y
Biomater Sci; 2015 Mar; 3(3):480-9. PubMed ID: 26222291
[TBL] [Abstract][Full Text] [Related]
13. Catechol polymers for pH-responsive, targeted drug delivery to cancer cells.
Su J; Chen F; Cryns VL; Messersmith PB
J Am Chem Soc; 2011 Aug; 133(31):11850-3. PubMed ID: 21751810
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic antitumor activity of HPMA copolymer-paclitaxel-alendronate conjugate on breast cancer bone metastasis mouse model.
Miller K; Eldar-Boock A; Polyak D; Segal E; Benayoun L; Shaked Y; Satchi-Fainaro R
Mol Pharm; 2011 Aug; 8(4):1052-62. PubMed ID: 21545170
[TBL] [Abstract][Full Text] [Related]
15. Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms.
Clementi C; Miller K; Mero A; Satchi-Fainaro R; Pasut G
Mol Pharm; 2011 Aug; 8(4):1063-72. PubMed ID: 21608527
[TBL] [Abstract][Full Text] [Related]
16. Dual pH-Responsive Shell-Cleavable Polycarbonate Micellar Nanoparticles for in Vivo Anticancer Drug Delivery.
Liu S; Ono RJ; Yang C; Gao S; Ming Tan JY; Hedrick JL; Yang YY
ACS Appl Mater Interfaces; 2018 Jun; 10(23):19355-19364. PubMed ID: 29757607
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma.
Gu Z; Wang X; Cheng R; Cheng L; Zhong Z
Acta Biomater; 2018 Oct; 80():288-295. PubMed ID: 30240956
[TBL] [Abstract][Full Text] [Related]
18. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.
Thamake SI; Raut SL; Gryczynski Z; Ranjan AP; Vishwanatha JK
Biomaterials; 2012 Oct; 33(29):7164-73. PubMed ID: 22795543
[TBL] [Abstract][Full Text] [Related]
19. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
[TBL] [Abstract][Full Text] [Related]
20. Calcium phosphate nanoparticles functionalized with alendronate-conjugated polyethylene glycol (PEG) for the treatment of bone metastasis.
Chu W; Huang Y; Yang C; Liao Y; Zhang X; Yan M; Cui S; Zhao C
Int J Pharm; 2017 Jan; 516(1-2):352-363. PubMed ID: 27887884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
